A Participatory Approach to Support Glucose Tolerance Tracking in Real-Life of Patients With Type 2 Diabetes

Launched by ENEA PARIMBELLI · Mar 3, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how we can help people with type 2 diabetes better manage their blood sugar levels using modern technology. The study will involve 20 people aged 40 to 70 who do not take insulin and are not very active. Participants will wear a continuous glucose monitor to track their blood sugar and an activity tracker for two weeks. During the first week, they will continue their usual daily activities, and in the second week, they will do some moderate exercise, like walking, every day. The goal is to see how these lifestyle changes affect their blood sugar levels.

To be eligible for the study, participants should have been diagnosed with type 2 diabetes, be physically inactive, and have specific blood sugar levels. This trial will not only measure changes in blood sugar but also test how easy it is to use the technology for tracking health data. Overall, this research aims to empower patients by involving them actively in their diabetes management.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Non-insulin treated T2D diagnosis (not treated at all or only with metformin);
• • Physically inactive (less than 150 minutes/week of moderate physical activity);
• • Age between 40 and 70;
• • HbA1c below 8.5%.
• Exclusion Criteria:
• • Diabetes diagnosis less than 3 years before the study initiation;
• • Pregnancy;
• • Symptomatic heart disease, e.g. history of myocardial infarction, coronary bypass, stenting procedure, angina, or any ischemic cerebrovascular event;
• • Use of a medication that significantly impacts glucose metabolism (oral steroids);
• • Use of a medication that significantly lowers heart rate (beta blockers, reserpine, guanethidine, methyldopa, clonidine, cimetidine, digitalis, calcium channel blockers, amiodarone, antiarrhythmic drugs, or lithium);
• • Atrial fibrillation;
• • Use of an electronic pacemaker.